INDIAN JOURNAL OF CANCER, vol.57, no.1, pp.55-61, 2020 (SCI-Expanded, Scopus)
Background and Aim: Our retrospective, single-center study aimed at evaluating the efficacy and safety of eribulin in heavily pretreated metastatic breast cancer (MBC) in routine clinical practice.